The Board of Directors consists of elected members of the Society. Meeting at least once annually, it is entrusted with the corporate governance and overall management of the ISBT. The Board sets the strategic direction of the Society. Its general and financial responsibilities are detailed in the Statutes. All permanent and ad hoc ISBT committees and working parties are appointed by the Board. The Board determines when and where international and regional congresses are to be held. The ISBT Board delegates specific management and administrative functions to the Executive Committee, who are all members of the Board. This committee in turn, works to ensure that the Society acts in accordance with Board decisions and with resolutions of the General Assembly.
The ISBT Board of Directors is composed of the members of the Executive Committee, together with nine Regional Directors. The Statutes designate that the Executive Committee is composed of the President, President Elect, Past President, Vice Presidents, Secretary General and the Treasurer.
Ravi Reddy is currently the Chief Operations Officer of South African National Blood Service (SANBS) and has worked for the Blood Transfusion Services in South Africa for 30 years. His responsibilities are to direct all aspects related to the Collection, Processing, Testing and Issue of approximately 823 000 units of blood in SANBS as well as developing and implementing strategic initiatives to improve blood supply and safety.
He is a member of the WHO expert committee on Blood Safety and biological standards and is also a non-executive Board member of the African Society for Blood Transfusion (AfSBT).
Martin L. Olsson received his M.D. (1991) and Ph.D. (1997) from Lund University in Sweden where he is a full Professor of Transfusion Medicine since 2006 and also the Deputy Head of a large research department. He is also the Medical Director of the Nordic Blood Group Reference Laboratory in Lund. He was a Visiting Scientist at IBGRL/BITS in Bristol, UK (1996) and a Visiting Associate Professor/Lecturer at Harvard Medical School (2003-2008). His main clinical and research interest involves the biochemistry, genetics and function of red cell surface molecules with a special emphasis on glycan blood groups and their role in host-pathogen interactions. He has received 12 awards from different organisations including ISBT, BBTS and AABB. He previously served on the Board of ISBT (2006-2008), as ISBT’s first Scientific Secretary (2011-2015).
Erica Wood is vice-president of ISBT, and a member of its working parties on clinical practice, haemovigilance, and transfusion-transmitted infectious diseases. From 2010-2014 she was ISBT regional director for the Western Pacific region. Erica is head of the Transfusion Research Unit in the Department of Epidemiology and Preventive Medicine at Monash University in Melbourne, Australia. She is a consultant haematologist at Monash Health and holds an honorary appointment at the Peter MacCallum Cancer Centre. Erica is president of the International Haemovigilance Network, past-president of the Australian and New Zealand Society of Blood Transfusion, and a member of the World Health Organization Expert Advisory Panel in Transfusion Medicine. Erica has served as Chief Examiner (Haematology) for the Royal College of Pathologists of Australasia and chair of the Joint Specialist Advisory Committee in Haematology. She is a member of the Victorian Blood Matters program advisory committee and the expert group of its Serious Transfusion Incident Reporting (STIR) haemovigilance program. In 2013, Erica was awarded a Churchill Fellowship to support her practice and research in patient blood management.
So-Yong is currently the Director of the Jungbu Blood Laboratory Center of the Korean Red Cross (KRC). She has been the Director of the Safety Bureau at the KRC Blood Services Headquarters, Director of the Blood Transfusion Research Institute, and Director of the Seoul Nambu Blood Center. As the current Director for Scientific Affairs of the Korean Society of Blood Transfusion (KSBT), she is responsible for organizing the scientific program of the KSBT annual meetings and for promoting educational and research activities among KSBT members.
Since 2006 she has been an active representative of the Asia Pacific Blood Network (APBN) and served as the Vice Chair of the APBN from 2015-2016.
Celso Bianco is the ISBT past-president. He grew up in São Paulo, Brazil and after medical school moved to New York to pursue a career in basic immunology at New York University, Rockefeller University and the State University of New York. He joined the New York Blood Center in 1982 and focused his research on viruses, bacteria and parasites of relevance for blood transfusion. He became the Vice President, Medical Affairs in 1992. In 2000, he joined America’s Blood Centers, a network of community based blood centers, becoming involved in policy-making related to blood donors and transfusion recipient safety, retiring in 2012. He has over 100 scientific publications and was an ISBT regional Director and member of the ISBT Board from 2002 to 2006.
Roger Dodd was born in England and obtained his BSc in biochemistry at the University of Sheffield in 1964. He worked as a Scientific Officer in the Ministry of Defence (UK) for about six years and in 1970 left for the United States to join the American Red Cross, where he worked for 44 years. He rapidly developed his research interest in transfusion-transmitted infections. During that time, he obtained his PhD in Microbiology at the George Washington University in 1978. In 2014, he retired from his position as Vice President, Research and Development, and Director of the Holland Laboratory where he was responsible for the Red Cross research programs supporting its blood program. He has more than 200 publications and has edited three books on transfusion transmitted infections. He has been an Advisor to WHO and he serves on the Editorial Boards of Transfusion and Transfusion Medicine and is a Past President of the AABB. He was elected to the position of Vice President on the ISBT Board in 2010 and is currently Secretary General. He has served as Chair of the Global Collaboration on Blood Safety. He has received the Morten Grove-Rasmussen and Emily Cooley Memorial Awards from the AABB, a Tiffany Award from the American Red Cross, and the John Snow award from the American Public Health Association.
Eric Jansen is currently working as an independent consultant in Blood Supply Chain Management. He is partner together with prof. dr. ir. Jan van der Wal in the company Blood Supply Chain Solutions. Eric retired in 2013 from his role as managing director of the Sanquin Blood Service Amsterdam in the Netherlands. Together with Steve Morgan he started and chaired the EBA Benchmarking project, aiming at performance improvement. Best practice are identified and via the EBA Flying Squad members in Europe (and US) were helped in the implementation of these best practices. Eric Jansen also worked in University and general hospitals in the Netherlands.
Nine Regional Directors are elected to represent the WHO regions. strategic direction of the Society and provide guidance on relevant issues, they promote the Society and the ISBT Academy and they act as a link between the ISBT and National and Regional Societies.
Justina Kordai Ansah is CEO of the National Blood Service Ghana, consultant physician in Transfusion Medicine, Fellow of the Ghana Postgraduate Medical College, a trainer and examiner. She is a board member of African Society for Blood Transfusion (AfSBT) as vice-president for ECOWAS region, and a member of WHO’s expert advisory panel on Blood Transfusion. Justina is chairperson of the working party on Blood Supply Management, member of working party on Donors and Donation, and the ISBT standing committee on ethics. She has several publications and contributed to a number of documents in blood safety for WHO and other organizations
Richard Benjamin is Chief Medical Officer of Cerus Corporation overseeing the Clinical Affairs and Device Safety departments, and is Professor of Laboratory Medicine and Pathology (adjunct) at Georgetown University, Washington, D.C. He is a Board certified Clinical Pathologist and Transfusion Medicine specialist with an interest in blood safety and pathogen inactivation. Dr. Benjamin previously served as Chief Medical Officer of the American Red Cross where he oversaw donor and patient safety issues, and as Medical Director of the Adult Transfusion Service at the Joint Program in Transfusion Medicine at Harvard University.
Ina Pérez is the Medical Chief of a clinical transfusional service as well as blood system in AUNA. Lima, Peru. Dedicated to educate and organize human resources in hemovigilance programs in AUNA bloodnet, she is keen to improve medical educaction in the field, as well as promote strategies for improvement in medical education, advocacy of blood donation and the clinical follow-up of blood donors. She has expertise in therapeutic apheresis techniques as a transfusion medicine consultant.
Miguel Lozano, MD, PhD is Haematologist. Currently he is Haemotherapy Section Head at the department of Haemotherapy and Haemostasis of the Clínic University Hospital in Barcelona, Spain. He is currently president of the European Society for Haemapheresis and chair of the AABB Press Editorial Board. He has been scientific member of BEST Collaborative since 2002. He is the author or co-author of over 175 papers, monographs and book chapters dealing with topics related with Transfusion Medicine and Hemostasis. He has co-edited books for AABB Press about Globalization in Transfusion Medicine, Blood Component Preparation and Platelet Transfusion Therapy.
Shubha Allard MD FRCP FRCPath, Consultant Haematologist, Barts Health NHS Trust and NHS Blood and Transplant, UK. Actively promoting Patient Blood Management with safe and appropriate use of blood and components at local, regional and national level. Lead Consultant Transfusion supervising the clinical and laboratory transfusion service across merged Barts Health NHS Trust comprising five hospitals. Clinical Tutor, NHSBT. Actively involved in education at undergraduate and postgraduate level. Vice chair of the British Society for Haematology Guidelines Committee developing national guidelines. Joint Chair ISBT Clinical Transfusion Working Party.
Ahmad Gharehbaghian is Professor of Clinical Immunohaematolgy at Shahid Beheshti University of Medical Sciences (SBUMS) in Tehran, Iran, where he is the Head of Laboratory Haematology and Blood Bank Department. He acts as the Editor-in-chief of the scientific journal Paramedical. He has an 18-year-long experience of working for Iranian Blood Transfusion Organization (IBTO) in different positions, The last of which is a 9-year-long deputyship for research and education and being the head of IBTO Research Center. Moreover, his background includes a few years of experiences as member of the Standing Committee of the ISBT Academy and the head of the international affairs at SBMUS. He is the author of 12 specialty books in Farsi, 46 articles in English and 36 articles in Farsi.
Since February 2015, Yuyun Soedarmono is staff of the Directorate of Primary Health Services, responsible for drafting and formulating the Government Regulation on Blood Services. From 2004-2015 she worked as a director of the Central Blood Transfusion Services of the Indonesian Red Cross (IRC) that is responsible for guiding, monitoring and evaluating the 211 IRC Blood Canters. As of 1994 she is involved in training and education about the blood service for the doctors, laboratory technicians and nurses, and also students of the Master Program of Transfusion Science – Faculty of Medicine – Indonesian University, and in 2010 started working as the Manager of this program. Since 2015, she is the President of the Indonesian Association of Transfusion Medicine (IATM). She is also affiliated to the WHO.
Lin Fung is Senior Lecturer of Medical Laboratory Science at the University of the Sunshine Coast, and has been the Chair of the ISBT Granulocyte Immunobiology Working Party since 2010. Her transfusion experience includes working as a scientist in busy tertiary hospital blood banks, leading a diagnostic and research team at the Australian Blood Service and leading a hospital based research team. She is a member of two hospital blood management committees and has an active interest in translational transfusion research. Lin enjoys public speaking, is passionate about evidence based transfusion practice and this is keen to promote this practice.
After graduating from the University of Hong Kong with an M.B., B.S. degree, Che-Kit Lin was trained in laboratory haematology and has obtained a Fellowship of the Royal College of Pathologists, Australasia, the Hong Kong Academy of Medicine (Pathology), the Hong Kong College of Pathologists and the Hong Kong College of Community Medicine, and MBA from the University of Birmingham, UK. Che-Kit joined the Hong Kong Red Cross Blood Transfusion Service (HKRCBTS) in 1990 and was its Chief Executive and Medical Director from 1995 to 2015. He was also the honorary Clinical Associate Professor, Department of Anatomical and Cellular Pathology, Chinese University of Hong Kong. In addition to many local professional bodies and government committees, he had also been actively involved in many international blood transfusion related bodies.